HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

EWTLELLEELKNEAVRHF Vpr(17-34) human epitope
    ELLEELKNEAVRHFP Vpr(21-35) human epitope
        ELKNEAVRHFPRIWLH Vpr(25-40) human epitope
        ELKNEAVRHFPRIWLH Vpr(25-40) human epitope
        ELKNEAVRHFPRIWLHGL Vpr(25-42) human epitope
        ELKNEAVRHFPRIWLHSL Vpr(25-42) human epitope
        ELKNEAVHFPRIWLHSL Vpr(25-42) human epitope
            EAVRHFPRI Vpr(29-37) A*33 human epitope
            EAVRHFPRI Vpr(29-37) A*68:02 human epitope
            EAVRHFPRI Vpr(29-37) B*18 human epitope
            EAVRHFPRI Vpr(29-37) B*27 human epitope
            EAVRHFPRI Vpr(29-37) B*35:01, B*35:08 human epitope
            EAVRHFPRI Vpr(29-37) B*35:02, B*35:03, B*53:01 human epitope
            EAVRHFPRI Vpr(29-37) B*51 epitope
            EAVRHFPRI Vpr(29-37) B*51 human epitope
            EAVRHFPRI Vpr(29-37) B*51 human epitope
            EAVRHFPRI Vpr(29-37) B*51 human epitope
            EAVRHFPRI Vpr(29-37) B*51 human epitope
            EAVRHFPRt Vpr(29-37) HLA association; processing
            EAVRHFPRa Vpr(29-37) HLA association; processing
            EAVRHFPRI Vpr(29-37) B51 epitope
            EAVRHFPRI Vpr(29-37) B51 human epitope
            EAVRHFPRI Vpr(29-37) B51 human epitope
            EAVRHFPRI Vpr(29-37) B51 human epitope
            EAVRHFPRI Vpr(29-37) B*51:01 human epitope
            EAVRHFPRt Vpr(29-37) diminished response
            EAVRHFPRl Vpr(29-37) escape documented in this paper
            EAVRHFPRI Vpr(29-37) B*51:01 human epitope
            EAVRHFPRt Vpr(29-37) diminished response
            EAVRHFPRl Vpr(29-37) diminished response
            EAVRHFPRI Vpr(29-37) B*51:01 human epitope
            EAVRHFPRt Vpr(29-37) diminished response
            EAVRHFPRl Vpr(29-37) diminished response
            EAVRHFPRI Vpr(29-37) B*81 human epitope
            EAVRHFPRI Vpr(29-37) C*06 human epitope
            EAVRHFPRI Vpr(29-37) human epitope
            EAVRHFPRI Vpr(29-37) human epitope
            EAVRHFPRLW Vpr(29-38) B*57 human epitope
            EAVRHFPRIWLHSLG Vpr(29-43) human epitope
            EAVRHFPRIWLHGLG Vpr(29-43) human epitope
            EAVRHFPRIWLHSLG Vpr(29-43) epitope
            EAVRHFPRIWLHGLG Vpr(29-43) human epitope
             AVRHFPRIW Vpr(30-38) B*18 human epitope
             AVRHFPRIW Vpr(30-38) B27 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRvW Vpr(30-38) observed variant
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B*57 human epitope
             AVRHFPRIW Vpr(30-38) B57 human epitope
             AVRHFPRIW Vpr(30-38) B57 human epitope
             AVRHFPRIW Vpr(30-38) B*58:01, B57 human epitope
             AVRHFPRIW Vpr(30-38) B57, B63 human epitope
             AVRHFPRIW Vpr(30-38) B*57:01 human epitope
             AVRHFPRIW Vpr(30-38) B*57:01 human epitope
             AVRHFPRIW Vpr(30-38) B*57:01 human epitope
             AVRHFPRPW Vpr(30-38) B*58:01 human epitope
             AVRHFPRIW Vpr(30-38) C*14 human epitope
             AVRHFPRIW Vpr(30-38) human epitope
             AVRHFPRIW Vpr(30-38) human epitope
             AVRHRPRIW Vpr(30-38) human epitope
             AVRHFRPIW Vpr(30-38) human epitope
              VRHFPRIWL Vpr(31-39) A*29 human epitope
              VRHFPRIWL Vpr(31-39) A*32 human epitope
              VRHFPRIWL Vpr(31-39) A*34 human epitope
              VRHFPRIWL Vpr(31-39) A*68:02 human epitope
              VRHFPRIWL Vpr(31-39) B*27 epitope
              VRHFPRIWL Vpr(31-39) B*27 human epitope
              VRHFPRLWL Vpr(31-39) B*27 human epitope
              VRHFPRLWi Vpr(31-39) observed variant
              VRHFPRIWL Vpr(31-39) B*27 human epitope
              VRHFPRIWL Vpr(31-39) B27 human epitope
              VRHFPRIWL Vpr(31-39) B27 human epitope
              VRHFPRIWL Vpr(31-39) B27 human epitope
              VRHFPRIWL Vpr(31-39) B*27:02 human epitope
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VkHFPRIWL Vpr(31-39) escape documented in this paper
              VRHFPxIWL Vpr(31-39) escape documented in this paper
              VRHFPRIWL Vpr(31-39) B*27:05 human epitope
              VRHFPRIWL Vpr(31-39) B*35:02, B*35:03, B*53:01 human epitope
              VRHFPRIWL Vpr(31-39) B*40 human epitope
              VRHFPRIWL Vpr(31-39) B*57 human epitope
              VRHFPRIWL Vpr(31-39) B*81 human epitope
              VRHFPRIWL Vpr(31-39) human epitope
              VRHFPRPWLHGLGQYIYETY Vpr(31-50) human epitope
              VRHFPRWLHSLGQYIYETY Vpr(31-50) human epitope
              VRHFPRPWLHSLGQYIYETY Vpr(31-50) human epitope
                HFPRPWLHN Vpr(33-41) human epitope
                HFPRIWLHGLG Vpr(33-43) human epitope
                HFPRIWLHSLGQHIY Vpr(33-47) human epitope
                HFPRIWLHSLGQHIY Vpr(33-47) human epitope
                 FPRPWLHGL Vpr(34-42) A2 human epitope
                 FPRPWLHsL Vpr(34-42) observed variant
                 FPRPWLHGL Vpr(34-42) A2 human, transgenic mouse epitope
                 FPRPWLHGL Vpr(34-42) A2 human epitope
                 FPRmWLHsL Vpr(34-42) observed variant
                 FPRiWLHsL Vpr(34-42) observed variant
                 FPPtWLHnL Vpr(34-42) observed variant
                 FPRvWLHnL Vpr(34-42) observed variant
                 FPRvWLHGL Vpr(34-42) observed variant
                 FPRiWLHnL Vpr(34-42) observed variant
                 FPRtWLHsL Vpr(34-42) observed variant
                 FPRmWLHnL Vpr(34-42) observed variant
                 FPRIWLHGL Vpr(34-42) A*29 human epitope
                 FPRIWLHGL Vpr(34-42) B*07 human, transgenic mouse epitope
                 FPRpWLHGL Vpr(34-42) susceptible form
                 FPRIWLHsL Vpr(34-42) susceptible form
                 FPRIWLHGL Vpr(34-42) B*07 human epitope
                 FPRIWLHGL Vpr(34-42) B*07:02 human epitope
                 FPRIWLHGL Vpr(34-42) B*07:02 human epitope
                 FPRWLHGL Vpr(34-42) B*07:02 human epitope
                 FPRIWLHGL Vpr(34-42) B*07:02 human epitope
                 FPRIWLHGL Vpr(34-42) B*07:02 human epitope
                 FPRIWLHSL Vpr(34-42) B*07:02 human epitope
                 FPRpWLHgL Vpr(34-42) subtype-specific susceptible form
                 FPRPWLHGL Vpr(34-42) B*07:02, B*42:01, B*81:01 human epitope
                 FPRPWLHGL Vpr(34-42) B*07:02, B*42:01, B*81:01 human epitope
                 FPRIWLHGL Vpr(34-42) B*08 human epitope
                 FPRIWLHGL Vpr(34-42) B*15:10 human epitope
                 FPRIWLHGL Vpr(34-42) B*39 human epitope
                 FPRIWLHGL Vpr(34-42) B*40 human epitope
                 FPRPWLHGL Vpr(34-42) B*42 human epitope
                 FPRvWLHGL Vpr(34-42) observed variant
                 FPRmWLHGL Vpr(34-42) observed variant
                 FPRPWLHGs Vpr(34-42) observed variant
                 FPRtWLHGL Vpr(34-42) observed variant
                 FPRaWLHGL Vpr(34-42) observed variant
                 FPRPWLHqL Vpr(34-42) observed variant
                 FPRPWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRPWLHGi Vpr(34-42) escape documented in this paper; observed variant
                 FPRPWLHGL{GQh} Vpr(34-42) escape documented in this paper; observed variant
                 FPRPWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRIWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRPWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRPWLHGL Vpr(34-42) B*42:01 human epitope
                 FPRPWLHGL Vpr(34-42) B*42:01, B*42:02 human epitope
                 FPRPWLHxL Vpr(34-42) escape documented in this paper
                 FPRPWLHGL Vpr(34-42) B7 human epitope
                 FPRPWLHGL Vpr(34-42) B7 human epitope
                 FPRiWLHGL Vpr(34-42) observed variant
                 FPRIWLHGL Vpr(34-42) B7 human epitope
                 FPRIWLHGL Vpr(34-42) B7 human epitope
                 FPRIWLHGL Vpr(34-42) B7 human epitope
                 FPRTWLHGL Vpr(34-42) B7 human epitope
                 FPwTWLHGL Vpr(34-42) diminished response
                 FPRIWLHGL Vpr(34-42) B7 human epitope
                 FPRIWLHGL Vpr(34-42) B7, B81 human epitope
                 FPRIWLHGL Vpr(34-42) B*81 human epitope
                 FPRIWLHGL Vpr(34-42) B*81:01 human epitope
                 FPRIWLHGL Vpr(34-42) B*81:01 human epitope
                 FPRIWLHGL Vpr(34-42) B*81:01 human epitope
                 FPRWLHGL Vpr(34-42) B*81:01 human epitope
                 FPRIWLHGL Vpr(34-42) C*02 human epitope
                 FPRPWLHSL Vpr(34-42) human epitope
                 FPRIWLHGL Vpr(34-42) human epitope
                 FPRIWLHGL Vpr(34-42) human epitope
                    IWLHSLGQHIYETYG Vpr(37-51) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health